Dr. Habashi is a pharmaceutical scientist specializing in drug–disease interaction, pharmacokinetics–pharmacodynamics (PK/PD) analysis, formulation, and delivery of small molecules and peptide drugs. He is the Acting Director of Idaho State University’s (ISU) Pharmaceutics Translation (P/T) core. Dr. Habashi's professional education and career experience merge clinical training and research interests from industrial and academic perspectives. As an Associate Professor in the Biomedical and Pharmaceutical Sciences Department, he teaches basic and advanced pharmacokinetics courses. Dr. Habashi's laboratory is interested in PK/PD analysis of drugs and focuses on exploring the concept of drug–disease interactions. His lab is particularly interested in the effects of inflammation on the Arachidonic Acid (ArA) pathway and the Renin–Angiotensin System (RAS) under different pathological conditions and has successfully designed innovative, targeted drug delivery systems for the effective, safe, and noninvasive delivery of small molecules and peptides that prolong their biological half-life and enhance their pharmacological effects.